Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.

Cardiovascular Diabetology
Yuze ZhangDajun Chai

Abstract

Cardiac remodeling is one of the major risk factors for heart failure. In patients with type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of the first hospitalization for heart failure, possibly through glucose-independent mechanisms in part, but the underlying mechanisms remain largely unknown. This study aimed to shed light on the efficacy of dapagliflozin in reducing cardiac remodeling and potential mechanisms. Sprague-Dawley (SD) rats, induced by chronic infusion of Angiotensin II (Ang II) at a dose of 520 ng/kg per minute for 4 weeks with ALZET® mini-osmotic pumps, were treated with either SGLT2 inhibitor dapagliflozin (DAPA) or vehicle alone. Echocardiography was performed to determine cardiac structure and function. Cardiac fibroblasts (CFs) were treated with Ang II (1 μM) with or without the indicated concentration (0.5, 1, 10 μM) of DAPA. The protein levels of collagen and TGF-β1/Smad signaling were measured along with body weight, and blood biochemical indexes. DAPA pretreatment resulted in the amelioration of left ventricular dysfunction in Ang II-infused SD rats without affecting blood glucose and blood pressure. Myocardial hypertrophy, fibrosis and increased collagen synthesis cause...Continue Reading

References

Nov 18, 2006·Cardiovascular Research·Marcin Bujak, Nikolaos G Frangogiannis
Dec 2, 2009·Nature Reviews. Cardiology·Susanne W M van den BorneJagat Narula
Jan 26, 2011·Circulation·Mark H Drazner
May 8, 2013·Cellular and Molecular Life Sciences : CMLS·Ping KongNikolaos G Frangogiannis
Apr 22, 2014·Current Pharmaceutical Design·Johan M Thijssen, Chris L de Korte
Jan 16, 2015·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Silvio E InzucchiOdd Erik Johansen
Oct 29, 2015·European Heart Journal·Otto A SmisethStig Urheim
Mar 19, 2016·Circulation Research·Joshua G TraversBurns C Blaxall
May 12, 2016·Journal of Molecular and Cellular Cardiology·April Stempien-OteroJennifer Davis
Sep 1, 2014·Journal of Echocardiography·Masashi SuzueShoji Kagami
Jun 25, 2016·Nature Reviews. Drug Discovery·Robert G GourdiePeter Kohl
Mar 18, 2017·Journal of the American College of Cardiology·Sumeet S MitterJames D Thomas
Apr 25, 2017·Nature Reviews. Cardiology·Michelle D Tallquist, Jeffery D Molkentin
Jan 27, 2018·Matrix Biology : Journal of the International Society for Matrix Biology·Li LiWei Kong
Jun 7, 2018·Physiological Reviews·Steven J ForresterSatoru Eguchi
Jul 30, 2018·Molecular Aspects of Medicine·Nikolaos G Frangogiannis
Oct 28, 2018·Cardiovascular Drugs and Therapy·Yumei YeYochai Birnbaum
Nov 23, 2018·Expert Opinion on Drug Metabolism & Toxicology·Alvaro Garcia-RoperoCarlos G Santos-Gallego
Feb 14, 2019·Postgraduate Medicine·Theodosios D FilippatosMoses S Elisaf
Mar 20, 2019·Basic Research in Cardiology·Lucas BacmeisterDiana Lindner
Jun 21, 2019·Circulation Research·Nikolaos G Frangogiannis
Aug 29, 2019·Korean Circulation Journal·Chang Myung OhYoung Guk Ko
Sep 20, 2019·The New England Journal of Medicine·John J V McMurrayUNKNOWN DAPA-HF Trial Committees and Investigators
Feb 27, 2020·Circulation Research·Shiju YeGuang Liang
Mar 29, 2020·JAMA : the Journal of the American Medical Association·Mark C PetrieJohn J V McMurray
Jul 16, 2020·Nature Reviews. Cardiology·Martin R Cowie, Miles Fisher
Nov 8, 2020·Cellular Signalling·Anis HannaNikolaos G Frangogiannis

❮ Previous
Next ❯

Software Mentioned

Image J
QTVI
SPSS statistics
Echopack
Q analysis

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.